Topotecan Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: T3D4AFB92426EN
Market Monitor Global

Abstracts

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

This report contains market size and forecasts of Topotecan in Global, including the following market information:

Global Topotecan Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Topotecan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Topotecan include GSK, Teva, Fresenius Kabi, Cipla, Sagent Pharmaceuticals, Mylan, Pfizer and Dr. Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topotecan companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Topotecan Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Topotecan Market Segment Percentages, by Type, 2021 (%)

• Capsules
• Injection

Global Topotecan Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Topotecan Market Segment Percentages, by Application, 2021 (%)

• Ovarian Cancer
• Lung Cancer
• Other Cancer types

Global Topotecan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Topotecan Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Topotecan revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Topotecan revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Teva
• Fresenius Kabi
• Cipla
• Sagent Pharmaceuticals
• Mylan
• Pfizer
• Dr. Reddy's Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Topotecan Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Topotecan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TOPOTECAN OVERALL MARKET SIZE

2.1 Global Topotecan Market Size: 2021 VS 2028
2.2 Global Topotecan Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Topotecan Players in Global Market
3.2 Top Global Topotecan Companies Ranked by Revenue
3.3 Global Topotecan Revenue by Companies
3.4 Top 3 and Top 5 Topotecan Companies in Global Market, by Revenue in 2021
3.5 Global Companies Topotecan Product Type
3.6 Tier 1, Tier 2 and Tier 3 Topotecan Players in Global Market
  3.6.1 List of Global Tier 1 Topotecan Companies
  3.6.2 List of Global Tier 2 and Tier 3 Topotecan Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Topotecan Market Size Markets, 2021 & 2028
  4.1.2 Capsules
  4.1.3 Injection
4.2 By Type - Global Topotecan Revenue & Forecasts
  4.2.1 By Type - Global Topotecan Revenue, 2017-2022
  4.2.2 By Type - Global Topotecan Revenue, 2023-2028
  4.2.3 By Type - Global Topotecan Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Topotecan Market Size, 2021 & 2028
  5.1.2 Ovarian Cancer
  5.1.3 Lung Cancer
  5.1.4 Other Cancer types
5.2 By Application - Global Topotecan Revenue & Forecasts
  5.2.1 By Application - Global Topotecan Revenue, 2017-2022
  5.2.2 By Application - Global Topotecan Revenue, 2023-2028
  5.2.3 By Application - Global Topotecan Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Topotecan Market Size, 2021 & 2028
6.2 By Region - Global Topotecan Revenue & Forecasts
  6.2.1 By Region - Global Topotecan Revenue, 2017-2022
  6.2.2 By Region - Global Topotecan Revenue, 2023-2028
  6.2.3 By Region - Global Topotecan Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Topotecan Revenue, 2017-2028
  6.3.2 US Topotecan Market Size, 2017-2028
  6.3.3 Canada Topotecan Market Size, 2017-2028
  6.3.4 Mexico Topotecan Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Topotecan Revenue, 2017-2028
  6.4.2 Germany Topotecan Market Size, 2017-2028
  6.4.3 France Topotecan Market Size, 2017-2028
  6.4.4 U.K. Topotecan Market Size, 2017-2028
  6.4.5 Italy Topotecan Market Size, 2017-2028
  6.4.6 Russia Topotecan Market Size, 2017-2028
  6.4.7 Nordic Countries Topotecan Market Size, 2017-2028
  6.4.8 Benelux Topotecan Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Topotecan Revenue, 2017-2028
  6.5.2 China Topotecan Market Size, 2017-2028
  6.5.3 Japan Topotecan Market Size, 2017-2028
  6.5.4 South Korea Topotecan Market Size, 2017-2028
  6.5.5 Southeast Asia Topotecan Market Size, 2017-2028
  6.5.6 India Topotecan Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Topotecan Revenue, 2017-2028
  6.6.2 Brazil Topotecan Market Size, 2017-2028
  6.6.3 Argentina Topotecan Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Topotecan Revenue, 2017-2028
  6.7.2 Turkey Topotecan Market Size, 2017-2028
  6.7.3 Israel Topotecan Market Size, 2017-2028
  6.7.4 Saudi Arabia Topotecan Market Size, 2017-2028
  6.7.5 UAE Topotecan Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Topotecan Major Product Offerings
  7.1.4 GSK Topotecan Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Topotecan Major Product Offerings
  7.2.4 Teva Topotecan Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Topotecan Major Product Offerings
  7.3.4 Fresenius Kabi Topotecan Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla Topotecan Major Product Offerings
  7.4.4 Cipla Topotecan Revenue in Global Market (2017-2022)
  7.4.5 Cipla Key News
7.5 Sagent Pharmaceuticals
  7.5.1 Sagent Pharmaceuticals Corporate Summary
  7.5.2 Sagent Pharmaceuticals Business Overview
  7.5.3 Sagent Pharmaceuticals Topotecan Major Product Offerings
  7.5.4 Sagent Pharmaceuticals Topotecan Revenue in Global Market (2017-2022)
  7.5.5 Sagent Pharmaceuticals Key News
7.6 Mylan
  7.6.1 Mylan Corporate Summary
  7.6.2 Mylan Business Overview
  7.6.3 Mylan Topotecan Major Product Offerings
  7.6.4 Mylan Topotecan Revenue in Global Market (2017-2022)
  7.6.5 Mylan Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Topotecan Major Product Offerings
  7.7.4 Pfizer Topotecan Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Dr. Reddy's Laboratories
  7.8.1 Dr. Reddy's Laboratories Corporate Summary
  7.8.2 Dr. Reddy's Laboratories Business Overview
  7.8.3 Dr. Reddy's Laboratories Topotecan Major Product Offerings
  7.8.4 Dr. Reddy's Laboratories Topotecan Revenue in Global Market (2017-2022)
  7.8.5 Dr. Reddy's Laboratories Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Topotecan Market Opportunities & Trends in Global Market
Table 2. Topotecan Market Drivers in Global Market
Table 3. Topotecan Market Restraints in Global Market
Table 4. Key Players of Topotecan in Global Market
Table 5. Top Topotecan Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Topotecan Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Topotecan Revenue Share by Companies, 2017-2022
Table 8. Global Companies Topotecan Product Type
Table 9. List of Global Tier 1 Topotecan Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Topotecan Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Topotecan Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Topotecan Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Topotecan Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Topotecan Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Topotecan Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Topotecan Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Topotecan Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Topotecan Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Topotecan Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Topotecan Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Topotecan Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Topotecan Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Topotecan Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Topotecan Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Topotecan Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Topotecan Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Topotecan Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Topotecan Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Topotecan Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Topotecan Product Offerings
Table 32. GSK Topotecan Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Topotecan Product Offerings
Table 35. Teva Topotecan Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Topotecan Product Offerings
Table 38. Fresenius Kabi Topotecan Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla Topotecan Product Offerings
Table 41. Cipla Topotecan Revenue (US$, Mn), (2017-2022)
Table 42. Sagent Pharmaceuticals Corporate Summary
Table 43. Sagent Pharmaceuticals Topotecan Product Offerings
Table 44. Sagent Pharmaceuticals Topotecan Revenue (US$, Mn), (2017-2022)
Table 45. Mylan Corporate Summary
Table 46. Mylan Topotecan Product Offerings
Table 47. Mylan Topotecan Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Topotecan Product Offerings
Table 50. Pfizer Topotecan Revenue (US$, Mn), (2017-2022)
Table 51. Dr. Reddy's Laboratories Corporate Summary
Table 52. Dr. Reddy's Laboratories Topotecan Product Offerings
Table 53. Dr. Reddy's Laboratories Topotecan Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Topotecan Segment by Type in 2021
Figure 2. Topotecan Segment by Application in 2021
Figure 3. Global Topotecan Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Topotecan Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Topotecan Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Topotecan Revenue in 2021
Figure 8. By Type - Global Topotecan Revenue Market Share, 2017-2028
Figure 9. By Application - Global Topotecan Revenue Market Share, 2017-2028
Figure 10. By Region - Global Topotecan Revenue Market Share, 2017-2028
Figure 11. By Country - North America Topotecan Revenue Market Share, 2017-2028
Figure 12. US Topotecan Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Topotecan Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Topotecan Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Topotecan Revenue Market Share, 2017-2028
Figure 16. Germany Topotecan Revenue, (US$, Mn), 2017-2028
Figure 17. France Topotecan Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Topotecan Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Topotecan Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Topotecan Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Topotecan Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Topotecan Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Topotecan Revenue Market Share, 2017-2028
Figure 24. China Topotecan Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Topotecan Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Topotecan Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Topotecan Revenue, (US$, Mn), 2017-2028
Figure 28. India Topotecan Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Topotecan Revenue Market Share, 2017-2028
Figure 30. Brazil Topotecan Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Topotecan Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Topotecan Revenue Market Share, 2017-2028
Figure 33. Turkey Topotecan Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Topotecan Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Topotecan Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Topotecan Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sagent Pharmaceuticals Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dr. Reddy's Laboratories Topotecan Revenue Year Over Year Growth (US$, Mn) & (2017-2022)